CHAMPIONS ONCOLOGY, INC. Operating Leases, Rent Expense
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Operating Leases, Rent Expense of $822.00 thousand for the 12-month period ending 2019-04-30, per its 10-K filed 2020-07-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2020-07-28
- CHAMPIONS ONCOLOGY, INC. operating leases, rent expense for the quarter ending 2019-04-30 was $239.00K, a 35.03% increase year-over-year.
- CHAMPIONS ONCOLOGY, INC. operating leases, rent expense for the quarter ending 2019-01-31 was $208.00K, a 19.54% increase year-over-year.
- CHAMPIONS ONCOLOGY, INC. operating leases, rent expense for the quarter ending 2018-10-31 was $187.00K, a 8.33% decline year-over-year.
- CHAMPIONS ONCOLOGY, INC. operating leases, rent expense for the quarter ending 2018-07-31 was $188.00K, a 84.31% increase year-over-year.
- CHAMPIONS ONCOLOGY, INC. operating leases, rent expense for fiscal 2019 was $822.00K, a 25.11% increase from fiscal 2018.
- CHAMPIONS ONCOLOGY, INC. operating leases, rent expense for fiscal 2018 was $657.00K, a 65.08% increase from fiscal 2017.
- CHAMPIONS ONCOLOGY, INC. operating leases, rent expense for fiscal 2017 was $398.00K, a 30.92% increase from fiscal 2016.
- CHAMPIONS ONCOLOGY, INC. operating leases, rent expense for fiscal 2016 was $304.00K, a 36.94% increase from fiscal 2015.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 9 month | Operating Leases, Rent Expense 12 month |
|---|---|---|---|---|
| 2019-04-30 | $239.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-28 | $447.00K derived: sum of 2 quarters · filed 2020-07-28 | $634.00K derived: sum of 3 quarters · filed 2020-07-28 | $822.00K 10-K · filed 2020-07-28 |
| 2019-01-31 | $208.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-18 | $395.00K derived: sum of 2 quarters · filed 2019-03-18 | $583.00K 10-Q · filed 2019-03-18 | $760.00K derived: sum of 4 quarters · filed 2019-07-29 |
| 2018-10-31 | $187.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-12-17 | $375.00K 10-Q · filed 2018-12-17 | $552.00K derived: sum of 3 quarters · filed 2019-07-29 | $726.00K derived: sum of 4 quarters · filed 2019-07-29 |
| 2018-07-31 | $188.00K 10-Q · filed 2018-09-14 | $365.00K derived: sum of 2 quarters · filed 2019-07-29 | $539.00K derived: sum of 3 quarters · filed 2019-07-29 | $743.00K derived: sum of 4 quarters · filed 2019-07-29 |
| 2018-04-30 | $177.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-29 | $351.00K derived: sum of 2 quarters · filed 2019-07-29 | $555.00K derived: sum of 3 quarters · filed 2019-07-29 | $657.00K 10-K · filed 2019-07-29 |
| 2018-01-31 | $174.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-18 | $378.00K derived: sum of 2 quarters · filed 2019-03-18 | $480.00K 10-Q · filed 2019-03-18 | $581.00K derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-10-31 | $204.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-12-17 | $306.00K 10-Q · filed 2018-12-17 | $407.00K derived: sum of 3 quarters · filed 2018-12-17 | $506.00K derived: sum of 4 quarters · filed 2018-12-17 |
| 2017-07-31 | $102.00K 10-Q · filed 2018-09-14 | $203.00K derived: sum of 2 quarters · filed 2018-09-14 | $302.00K derived: sum of 3 quarters · filed 2018-09-14 | $401.00K derived: sum of 4 quarters · filed 2018-09-14 |
| 2017-04-30 | $101.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-30 | $200.00K derived: sum of 2 quarters · filed 2018-07-30 | $299.00K derived: sum of 3 quarters · filed 2018-07-30 | $398.00K 10-K · filed 2018-07-30 |
| 2017-01-31 | $99.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-19 | $198.00K derived: sum of 2 quarters · filed 2018-03-19 | $297.00K 10-Q · filed 2018-03-19 | $385.00K derived: sum of 4 quarters · filed 2018-03-19 |
| 2016-10-31 | $99.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-12-15 | $198.00K 10-Q · filed 2017-12-15 | $286.00K derived: sum of 3 quarters · filed 2017-12-15 | $392.00K derived: sum of 4 quarters · filed 2017-12-15 |
| 2016-07-31 | $99.00K 10-Q · filed 2017-09-14 | $187.00K derived: sum of 2 quarters · filed 2017-09-14 | $293.00K derived: sum of 3 quarters · filed 2017-09-14 | $350.00K derived: sum of 4 quarters · filed 2017-09-14 |
| 2016-04-30 | $88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28 | $194.00K derived: sum of 2 quarters · filed 2017-07-28 | $251.00K derived: sum of 3 quarters · filed 2017-07-28 | $304.00K 10-K · filed 2017-07-28 |
| 2016-01-31 | $106.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-17 | $163.00K derived: sum of 2 quarters · filed 2017-03-17 | $216.00K 10-Q · filed 2017-03-17 | |
| 2015-10-31 | $57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-14 | $110.00K 10-Q · filed 2016-12-14 | ||
| 2015-07-31 | $53.00K 10-Q · filed 2016-09-14 | |||
| 2015-04-30 | $222.00K 10-K · filed 2016-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |